GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: (S)-(+)-Ketamine | (S)-Ketamine | Spravato®
esketamine is an approved drug (EMA & FDA (2019))
Compound class:
Synthetic organic
Comment: As the ketamine (S) enatiomer esketamine is twice as potent and has a more medically useful pharmacological action than racemic ketamine. Part of this advantage arises from inhibition of dopamine transporters.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. EU EMA (2019) | US FDA (2019) |
IUPAC Name ![]() |
| (2S)-2-(2-chlorophenyl)-2-methylaminocyclohexan-1-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7884 | esketamine |
Synonyms ![]() |
| (S)-(+)-Ketamine | (S)-Ketamine | Spravato® |
Database Links ![]() |
|
| ChEMBL Ligand | CHEMBL395091 |
| DrugCentral Ligand | 4468 |
| GtoPdb PubChem SID | 315661237 |
| PubChem CID | 182137 |
| RCSB PDB Ligand | JC9 |
| Search Google for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N |
| Search Google for chemicals with the same backbone | YQEZLKZALYSWHR |
| Search PubMed clinical trials | esketamine |
| Search PubMed titles | esketamine |
| Search PubMed titles/abstracts | esketamine |
| UniChem Compound Search for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N |
| Wikipedia | Esketamine |